Elizabeth Anderson
LeapRate Analyst

With over a decade’s experience as a finance writer, Elizabeth Anderson applies her knowledge and experience to keep a finger on the pulse of global trends. Specialising in forex, cryptocurrencies, and stocks, Elizabeth follows the movements that impact the world of trading.
October 13, 2023 BY Elizabeth Anderson

UGL lands significant contract with Power Network Services in Victoria

A growing demand for power infrastructure upgrades underpins this contract. As it stands, the deal can potentially generate $80m in UGL revenue. The agreement also includes options for extension.  The CIMIC group is a diverse engineering-based enterprise focusing on construction, mining, relevant services, and public-private partnerships. UGL is the service specialist branch of this business. Don’t…

Read more
October 13, 2023 BY Elizabeth Anderson

Yandex eager to prove its Yango app doesn’t breach data privacy regulations in Europe

In August, regulators in Finland and Norway announced their intentions to ban Yango from transferring data. This decision was however revoked and seems to be a knee-jerk response to controversial legislation that came into effect on 1 September.  This law grants Russia access to data processed through taxi services. The Dutch authorities reacted similarly and…

Read more
October 13, 2023 BY Elizabeth Anderson

Coinbase’s (COIN) spot trading volume down 52% in Q3

Coinbase’s volume has been on a steady decline since Q4 2021, a boom year for the industry. It closed that year with more than $400bn in volume. The broader cryptocurrency market has contracted during the last 18 months, making it more difficult for exchanges to drive growth. However, Coinbase did gain market share in Q3 as…

Read more
October 12, 2023 BY Elizabeth Anderson

Success of Ozempic kidney failure trials proves disastrous for dialysis stocks

The company indicated the trial would come to an end, approximately a year before scheduled completion, following a recommendation from an independent data monitoring committee. Ozempic, a treatment commonly used for Type 2 Diabetes, contains semaglutide. The trial aimed to discover if it could stem the progress of kidney disease and help with associated complications. …

Read more
October 11, 2023 BY Elizabeth Anderson

IMAX China votes against privatisation transaction

Despite 70% of shareholders voting in favour of the $124m buyout, the votes against surpassed the 10% limit stipulated by Hong Kong Law to defeat a privatisation deal. Currently, the IMAX Corporation, which is parent to IMAX China, owns 71.6% of its subsidiary. It needed 75% of the votes to get the deal through.  In…

Read more
October 11, 2023 BY Elizabeth Anderson

GMHBA announces appointment of Michael Sammels to its board

The newly-appointed GMBHA board member previously held the position of chief financial officer at both Medibank Private and Healthscope. In this role, Sammels gained extensive knowledge and experience in private health insurance and hospital landscapes. Don’t miss out the latest news, subscribe to LeapRate’s newsletter The company believes his expertise in finance, accounting, capital developments, and…

Read more
October 10, 2023 BY Elizabeth Anderson

Impact of Israel-Hamas conflict on global stock movements

The global financial sphere kept a close eye on stocks to identify and track the specific geopolitical risks as relevant markets opened on Monday. Analysts predicted a rise in the buying of assets such as gold and US currency, followed by an increased demand for US Treasuries.  In line with these predictions, US stock futures…

Read more